ATE250630T1 - Kristalle von fragmenten von cd40-liganden und deren verwendung - Google Patents

Kristalle von fragmenten von cd40-liganden und deren verwendung

Info

Publication number
ATE250630T1
ATE250630T1 AT96922527T AT96922527T ATE250630T1 AT E250630 T1 ATE250630 T1 AT E250630T1 AT 96922527 T AT96922527 T AT 96922527T AT 96922527 T AT96922527 T AT 96922527T AT E250630 T1 ATE250630 T1 AT E250630T1
Authority
AT
Austria
Prior art keywords
crystals
fragments
ligands
ligand
relates
Prior art date
Application number
AT96922527T
Other languages
English (en)
Inventor
Mihail N Karpusas
Juswinder Singh
David W Thomas
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Application granted granted Critical
Publication of ATE250630T1 publication Critical patent/ATE250630T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
AT96922527T 1995-06-22 1996-06-21 Kristalle von fragmenten von cd40-liganden und deren verwendung ATE250630T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44895P 1995-06-22 1995-06-22
PCT/US1996/010664 WO1997000895A1 (en) 1995-06-22 1996-06-21 Crystals of fragments of cd40 ligand and their use

Publications (1)

Publication Number Publication Date
ATE250630T1 true ATE250630T1 (de) 2003-10-15

Family

ID=21691579

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96922527T ATE250630T1 (de) 1995-06-22 1996-06-21 Kristalle von fragmenten von cd40-liganden und deren verwendung

Country Status (10)

Country Link
EP (1) EP0833847B1 (de)
JP (2) JPH11508262A (de)
AT (1) ATE250630T1 (de)
AU (1) AU6337296A (de)
CA (1) CA2224812A1 (de)
DE (1) DE69630120T2 (de)
DK (1) DK0833847T3 (de)
ES (1) ES2202455T3 (de)
PT (1) PT833847E (de)
WO (1) WO1997000895A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834228A (en) * 1997-02-13 1998-11-10 Merck & Co., Inc. Method for identifying inhibitors for apopain based upon the crystal structure of the apopain: Ac-DEVD-CHO complex
EP1754490A3 (de) 1997-06-20 2010-01-20 Biogen Idec MA Inc. CD154-Blockadetherapie der Pankreasinselzellentransplantation bei Primaten
SK16742000A3 (sk) 1998-05-12 2001-07-10 Warner-Lambert Company Kombinácie proteínovej farnesyltransferázy a inhibítorov hmg coa reduktázy a ich použitie pri liečbe rakoviny
AU8867501A (en) * 2000-09-01 2002-03-13 Biogen Inc Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
CN100439397C (zh) 2001-02-09 2008-12-03 基因技术股份有限公司 Igf-1的结晶
WO2013036829A1 (en) 2011-09-09 2013-03-14 Genentech, Inc Treatment of th17 mediated inflammatory diseases
CN112151122B (zh) * 2020-09-10 2025-02-21 国家纳米科学中心 结构未知晶体衍射能力的计算方法及物相定量分析方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2198025T3 (es) * 1991-10-25 2004-01-16 Immunex Corporation Anticuerpos contra cd40-l.
IL104684A0 (en) * 1992-02-14 1993-06-10 Bristol Myers Squibb Co The cd40cr receptor and ligands therefor
US5540926A (en) * 1992-09-04 1996-07-30 Bristol-Myers Squibb Company Soluble and its use in B cell stimulation
AU677995B2 (en) * 1993-01-22 1997-05-15 Immunex Corporation Detection and treatment of mutations in a CD40 ligand gene

Also Published As

Publication number Publication date
CA2224812A1 (en) 1997-01-09
EP0833847B1 (de) 2003-09-24
JP2006188541A (ja) 2006-07-20
WO1997000895A1 (en) 1997-01-09
JPH11508262A (ja) 1999-07-21
PT833847E (pt) 2004-02-27
AU6337296A (en) 1997-01-22
DE69630120D1 (de) 2003-10-30
HK1010085A1 (en) 1999-06-11
ES2202455T3 (es) 2004-04-01
EP0833847A1 (de) 1998-04-08
DK0833847T3 (da) 2003-12-29
DE69630120T2 (de) 2004-04-08

Similar Documents

Publication Publication Date Title
ATE280160T1 (de) Substituierte aryl-oder heteroarylamide mit retinoid-ähnlicher biologischer aktivität
NO20011174L (no) Nye heteroaromatiske inhibitorer av fruktose-1,6-bisfosfotase
DE68916512D1 (de) Zusammensetzung zur Verminderung von postoperativen Adhäsionen und ihre Verwendung.
ATE255906T1 (de) Antikörper gegen cd40
ATE364592T1 (de) Tyrosinderivate
BG101747A (en) Cycloalkanopyridines
DE69528475D1 (de) Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie
ATE399007T1 (de) Raf kinase hemmer
ATE217754T1 (de) Verwendung von aerogelen in der landwirtschaft
ATE295519T1 (de) Behandlung von kohlenwasserstoffgas
ATE161582T1 (de) Monoklonale antikörper der maus
DE69708848D1 (de) Mischung von erdalkalialkylarylsulfonaten, ihre verwendung als schmierölzusatz und herstellungsmethode
ATE178886T1 (de) 1-aryl-2-acylamino-ethan-verbindungen und ihre verwendung als neurokinin- insbesondere als neurokinin-1-antagonisten
ATE388399T1 (de) Verwendung von hroralpha rezeptoren zur auffindung von anti-atherosclerotischen verbindungen
ATE250630T1 (de) Kristalle von fragmenten von cd40-liganden und deren verwendung
ATE332356T1 (de) Verwendung von metallkomplexverbindungen als oxidationskatalysatoren
TR200003606T2 (tr) Yüksek çinko oluşumlu yeni insülin benzerleri.
HK1039341A1 (zh) α1β1合成(「α1β1」)I-领域的结晶体及其使用
YU36104A (sh) Kristalna struktura fosfodiesteraza 5 i njihova upotreba
DE69940971D1 (de) Verwendung von erythropoietin zur behandlung von primärer hämochromatosen
ATE184199T1 (de) Verwendung von lokal appliziertem faktor xiii zur verhinderung von blutungen
DE3484912D1 (de) Peptidderivate und deren verwendung als substrate zur quantitativen bestimmung von enzymen.
DE69711422D1 (de) Verwendung von (r)-verapamil als medizin zur behandlung von angina
NO971325L (no) Fremgangsmåte for fremstilling av 3,4-dihydroksy-5-nitrobenzaldehyd
FR2768730B1 (fr) Procede de photostabilisation du 4-(ter.butyl) 4'-methoxy dibenzoylmethane, compositions filtrantes ainsi obtenues et leurs utilisations

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0833847

Country of ref document: EP

REN Ceased due to non-payment of the annual fee